Ascendia Pharmaceutical Solutions attends CPHI Milan 2026, schedules partner meetings with CEO Huang and CCO Bloder

PUBT · 19h ago
Ascendia Pharmaceutical Solutions attends CPHI Milan 2026, schedules partner meetings with CEO Huang and CCO Bloder
  • Ascendia Pharmaceutical Solutions will attend CPHI Milan 2026 on Oct. 6-8 at Fiera Milano in Italy.
  • Founder and CEO Jingjun (Jim) Huang, PhD, will be available for meetings with prospective partners, alongside Chief Commercial Officer Robert Bloder.
  • Talks will focus on development strategy, formulation challenges, manufacturing planning, scale-up, technology transfer, clinical supply, and commercial manufacturing preparation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendia Pharmaceuticals Inc. published the original content used to generate this news brief on September 22, 2026, and is solely responsible for the information contained therein.